Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 3, 2025 · Filed Sep 5, 2025
An Ionis Pharmaceuticals director sold $1.68M of Ionis Pharmaceuticals shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,680,000
Shares × reported transaction price
35 days after results of Jul 30, 2025, 56 days before results of Oct 29, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Joseph Iii Klein's largest sale of IONS in their filings since 2008
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.1% | +1.6% | +1.6% |
| 30 days | +12.7% | +3.8% | +8.9% |
| 90 days | +33.6% | +5.7% | +27.9% |
| 180 days | +29.8% | +5.8% | +23.9% |
| 365 days | −7.4% | +18.3% | −25.7% |
Past results only. Not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.